Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.05 Mil
% of Total Estimate Gain
103.86%

Propel Bio Management, LLC's Kymera Therapeutics Inc Holding Summary

As of 2025-03-31, Propel Bio Management, LLC held - shares of Kymera Therapeutics Inc(KYMR), totaling N/A. This investment constitutes 0% of their stock portfolio, and Propel Bio Management, LLC now holds 0% of the outstanding Kymera Therapeutics Inc(KYMR) stock.

The initial trade took place in 2023Q4. In addition, there have been 1 sales at an average price of $36.45 for 56,359.00 shares. Based on historical transaction data and KYMR's current price of $46.18, Propel Bio Management, LLC's estimated gain on his KYMR holdings is $1.05 Mil, reflecting a 103.86% gain to date.

Propel Bio Management, LLC KYMR ($46.18) Holding Chart

Propel Bio Management, LLC KYMR ($46.18) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1